Osteopore Signs Non-Binding Term Sheet With CellHeal Which Will Commit AUD 10M To Accelerate Commercialisation In China
Medical Device Investing Osteopore to Acquire Multiple Medical Distribution Businesses & Become Vertically Integrated
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee
Finlay Minerals Appoints an Executive Chairman, President & CEO, and Vice President, Corporate Development
